Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bemnder HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997, 75: 429-439. 10.1007/s001090050128.
Article
CAS
PubMed
Google Scholar
Ilyas M, Straub J, Tomlinson IP, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999, 35: 1986-2002. 10.1016/S0959-8049(99)00298-1.
Article
CAS
PubMed
Google Scholar
Sager R: Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA. 1997, 94: 952-955. 10.1073/pnas.94.3.952.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schor SL, Schor AM, Howell A, Crowther D: Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp Cell Biol. 1987, 55: 11-17.
CAS
PubMed
Google Scholar
Schor SL, Schor AM: Stromal acceleration of tumour progression: role of 'fetal-like' fibroblast subpopulations. Pathol Update. 1997, 4: 75-95.
Google Scholar
Noel A, Foidart JM: The role of the stroma in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia. 1998, 3: 215-225. 10.1023/A:1018703208453.
Article
CAS
PubMed
Google Scholar
Mackenzie I: Epithelial-mesenchymal interactions in the development and maintenance of epithelial tissues. In:The Keratinocyte Handbook. Edited by Leigh IM, Lane EB, Watt FM. Cambridge: Cambridge University Press. 1994, 243-258.
Google Scholar
de Jong JS, van Diest PJ, van der Valk P, Baak JP: Expression of growth factors, growth inhibitory factors and their receptors in invasive breast cancer: an inventory in search of autocrine and paracrine loops. J Pathol. 1998, 184: 44-52. 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.3.CO;2-8.
Article
CAS
PubMed
Google Scholar
Rasmussen AA, Cullen : Paracrine/autocrine regulation of breast cancer by insulin-like growth factors. Breast Cancer Res Treat. 1998, 47: 219-233. 10.1023/A:1005903000777.
Article
CAS
PubMed
Google Scholar
Juliano R: Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessay. 1996, 18: 911-917.
Article
CAS
Google Scholar
Schor SL: Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog Growth Factor Res. 1994, 5: 223-248.
Article
CAS
PubMed
Google Scholar
Streuli C: Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol. 1999, 11: 634-640. 10.1016/S0955-0674(99)00026-5.
Article
CAS
PubMed
Google Scholar
Lee YJ, Strueli CH: Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands. J Biol Chem. 1999, 274: 22401-22408. 10.1074/jbc.274.32.22401.
Article
CAS
PubMed
Google Scholar
Ellis I, Schor SL: The interdependent modulation of hyaluronan synthesis by TGF-β1 and extracellular matrix: consequences for the control of cell migration. Growth Factors. 1995, 12: 211-222.
Article
CAS
PubMed
Google Scholar
Madri JA, Pratt BM, Tucker AM: Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol. 1988, 106: 1375-1384.
Article
CAS
PubMed
Google Scholar
Ellis IR, Banyard J, Schor SL: Motogenic and biosynthetic response of adult skin fibroblasts to TGF isoforms (-1, -2, and -3) determined by 'tissue response unit': role of cell density and substratum. Cell Biol Int. 1999, 23: 593-602. 10.1006/cbir.1999.0423.
Article
CAS
PubMed
Google Scholar
Schor AM, Schor SL, Allen TD: Effects of culture conditions on the proliferation and morphology of bovine aortic endothelial cells in vitro: reversible expression of the sprouting cell phenotype. J Cell Sci. 1983, 62: 267-285.
CAS
PubMed
Google Scholar
Canfield AE, Boot-Handford RP, Schor AM: Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem J. 1990, 268: 225-230.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ingber DE: Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol. 1997, 59: 575-599. 10.1146/annurev.physiol.59.1.575.
Article
CAS
PubMed
Google Scholar
Bassett P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Pod-hajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990, 348: 699-704. 10.1038/348699a0.
Article
Google Scholar
Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Lohrs U: Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Anticancer Res. 1999, 19: 4257-4264.
CAS
PubMed
Google Scholar
Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996, 149: 273-282.
CAS
PubMed
PubMed Central
Google Scholar
McCawley LJ, Matrisian LM: Matrix metalloproteinases: multi-functional contributors to tumor progression. Mol Med Today. 2000, 6: 149-156. 10.1016/S1357-4310(00)01686-5.
Article
CAS
PubMed
Google Scholar
Davis GE, Bayless KJ, Davis MJ, Meininger GA: Regulation of tissue injury responses by exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol. 2000, 156: 1489-1498.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stetler-Stevenson WG, Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol. 2001, 11: 143-153. 10.1006/scbi.2000.0365.
Article
CAS
PubMed
Google Scholar
Fukai F, Ohtaki M, Fugii N, Yajima H, Ishii T, Nishizawa Y, Miyazaki K, Katayama T: Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry. 1995, 34: 11453-11459.
Article
CAS
PubMed
Google Scholar
Newham P, Humphries MJ: Integrin adhesion receptors: structure, function and implications for biomedicine. Mol Med Today. 1996, 2: 304-313. 10.1016/1357-4310(96)10021-6.
Article
CAS
PubMed
Google Scholar
Schor SL, Ellis I, Dolman C, Banyard J, Humphries MJ, Mosher DF, Grey AM, Mould AP, Sotille J, Schor AM: Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J Cell Sci. 1996, 109: 2581-2590.
CAS
PubMed
Google Scholar
Schor SL, Ellis I, Banyard J, Schor AM: Motogenic activity of the IGD amino acid motif. J Cell Sci. 1999, 112: 3879-3888.
CAS
PubMed
Google Scholar
Schor SL, Schor AM, Rushton G, Smith L: Adult, fetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during fetal development. J Cell Sci. 1985, 73: 221-234.
CAS
PubMed
Google Scholar
Durning P, Schor SL, Sellwood RA: Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet. 1984, 2: 890-892. 10.1016/S0140-6736(84)90653-6.
Article
CAS
PubMed
Google Scholar
Schor SL, Haggie JA, Durning P, Howell A, Sellwood RA, Crowther D: Occurrence of a foetal fibroblast phenotype in familial breast cancer. Int J Cancer. 1986, 37: 831-836.
Article
CAS
PubMed
Google Scholar
Haggie J, Schor SL, Howell A, Birch JM, Sellwood RAS: Fibroblasts from relatives of hereditary breast cancer patients display fetal-like behaviour in vitro. Lancet. 1987, 1: 1455-1457. 10.1016/S0140-6736(87)92206-9.
Article
CAS
PubMed
Google Scholar
Schor SL, Schor AM, Grey AM, Rushton G: Foetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J Cell Sci. 1988, 90: 391-399.
CAS
PubMed
Google Scholar
Picardo M, Schor SL, Grey AM, Howell A, Laidlaw I, Redford J, Schor AM: Migration stimulating activity in the serum of breast cancer patients. Lancet. 1991, 337: 130-133. 10.1016/0140-6736(91)90798-T.
Article
CAS
PubMed
Google Scholar
Grey AM, Schor AM, Rushton G, Ellis I, Schor SL: Purification of the migration stimulating factor produced by fetal and cancer patient fibroblasts. Proc Natl Acad Sci USA. 1989, 86: 2438-2442.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schor SL, Grey AM, Ellis I, Schor AM, Coles B, Murphy R: Migration stimulating factor: its structural homology to the gelatin-binding domain of fibronectin, mode of action and possible function in health and disease. In:Cell Behaviour: Adhesion and Motility, S.E.B. Symposium No. 47. Edited by Evans G, Wigley C, Warn R. 1993, 235-251.
Google Scholar
Schor SL, Schor AM, Grey AM, Chen J, Rushton G, Grant ME, Ellis I: Mechanism of action of the migration stimulating factor (MSF) produced by fetal and cancer patient fibroblasts: effect on hyaluronic acid synthesis. In Vitro Cell Dev Biol. 1989, 25: 737-746.
Article
CAS
PubMed
Google Scholar
Schor AM, Rushton G, Ferguson JE, Howell A, Redford J, Schor SL: Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int J Cancer. 1994, 59: 25-32.
Article
CAS
PubMed
Google Scholar
Midulla M, Verma R, Pignatelli M, Ritter MA, Courtenay-Luck NS, George AJ: Source of oncofetal ED-B fibronectin: implications of production by both tumor and endothelial cells. Cancer Res. 2000, 60: 164-169.
CAS
PubMed
Google Scholar
Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zarde L: The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer. 1994, 59: 612-618.
Article
CAS
PubMed
Google Scholar
Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF: Vascular stroma formation in carcinoma in situ, invasive carcinoma and metastatic carcinoma of the breast. Clin Cancer Res. 1999, 5: 1041-1056.
CAS
PubMed
Google Scholar
Ellis I, Grey AM, Schor AM, Schor SL: Antagonistic effects of transforming growth factor beta and MSF on fibroblast migration and hyaluronic acid synthesis: possible implications for wound healing. J Cell Sci. 1992, 102: 447-456.
CAS
PubMed
Google Scholar
Spanakis E, Brouty-Boye D: Quantitative variation in proto-oncogene and cytokine gene expression in isolated breast fibroblasts. Int J Cancer. 1995, 61: 698-705.
Article
CAS
PubMed
Google Scholar
Spanakis E, Brouty-Boye D: Discrimination of fibroblast subtypes by multivariate analysis of gene expression. Int J Cancer. 1997, 71: 402-409. 10.1002/(SICI)1097-0215(19970502)71:3<402::AID-IJC17>3.3.CO;2-K.
Article
CAS
PubMed
Google Scholar
Singer CF, Rasmussen A, Lippman ME, Cullen KJ: Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal and endodermal origin: indicator of a fetal cell phenotype. J Clin Endocrinol Metab. 1997, 82: 1917-1922. 10.1210/jc.82.6.1917.
CAS
PubMed
Google Scholar
Moinifar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA: Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 2000, 60: 2562-2566.
Google Scholar